Cytori Reports Publication Of Cardiovascular Preclinical Study; Adipose Stem & Regenerative Cells Improve Function In Heart Attack Model

Main Category: Cardiovascular / Cardiology
Also Included In: Heart Disease
Article Date: 31 May 2009 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

4.67 (3 votes)

Healthcare Prof:2 stars

2 (1 votes)


Cytori (NASDAQ: CYTX) announced publication of the first preclinical study to demonstrate adipose-derived stem and regenerative cells (ADRCs) significantly improved cardiac function after a heart attack. This preclinical cardiac cell therapy study was reported online ahead of print in the International Journal of Cardiology. The study was funded by Cytori Therapeutics and conducted at Tulane University.

"Treatment of cardiovascular disease, which places one of the greatest burdens on our healthcare system, could be revolutionized by cell therapy," said Marc H. Hedrick, M.D., president of Cytori. "We observed a statistically significant improvement in heart function that contributed to our decision to proceed with our APOLLO study. Cardiovascular disease is the most advanced application in Cytori's product pipeline and could eventually make a substantial contribution to our future commercial activities."

The APOLLO study is the first clinical trial to investigate uncultured adipose-derived stem and regenerative cells in heart attacks in human patients. Enrollment was recently completed in APOLLO, a double blind, placebo controlled, safety and feasibility trial. Data are expected to be reported in early 2010. The APOLLO study is sponsored by Cytori and has incorporated the Company's Celution® System to automate the processing of the patients' cells at the point of care.

In Cytori's preclinical study, 17 large animals (pigs) were treated with their own uncultured adipose-derived stem and regenerative cells immediately following induction of a severe myocardial infarction. Uncultured cells include a multitude of heterogeneous cell types that Cytori believes facilitate several therapeutic mechanisms. Several functional measurements within the study indicated statistically significant improvement in both heart function and structure.

Source
Cytori

Article adapted by Medical News Today from original press release.
Visit our cardiovascular / cardiology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Cytori. "Cytori Reports Publication Of Cardiovascular Preclinical Study; Adipose Stem & Regenerative Cells Improve Function In Heart Attack Model." Medical News Today. MediLexicon, Intl., 31 May. 2009. Web.
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/151934.php>

APA
Cytori. (2009, May 31). "Cytori Reports Publication Of Cardiovascular Preclinical Study; Adipose Stem & Regenerative Cells Improve Function In Heart Attack Model." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/151934.php.

Please note: If no author information is provided, the source is cited instead.




Cardiovascular / Cardiology

What Is Heart Rate?

A person's heart rate, also known as their pulse, refers to how many times their heart beats per minute. Our heart rates vary tremendously, depending on the demands we make on our bodies. Read more...

Most Popular Articles



Follow Our Cardiovascular News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cardiovascular / Cardiology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »